Drugs / PuraStat®
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial | ||||||
| Phase 2/3 | NCT03917862 | Dec 2018 → Dec 2020 | aneurysm or dilatation of ascending aorta, arterial disorder | University of Sao Paulo General Hospital | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06896409 | Oct 2023 → Oct 2025 overdue | — | Tallaght University Hospital | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PuraStat | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06896409 ↗ |
| Known as | TDM-621 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03917862 ↗ |
| Modality | Peptide | “composed of nanofibers of a self-supporting polypeptide” NCT03917862 ↗ |